Voloridge Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$129M |
| 2 |
Walmart Inc
WMT
|
+$108M |
| 3 |
Halliburton
HAL
|
+$80M |
| 4 |
Netflix
NFLX
|
+$71.5M |
| 5 |
Merck
MRK
|
+$70M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$140M |
| 2 |
Bank of America
BAC
|
+$122M |
| 3 |
Broadcom
AVGO
|
+$86M |
| 4 |
Alibaba
BABA
|
+$70.9M |
| 5 |
Nike
NKE
|
+$67.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.16% |
| 2 | Technology | 17.15% |
| 3 | Consumer Discretionary | 13.05% |
| 4 | Industrials | 9.89% |
| 5 | Communication Services | 8.91% |
Similar funds
Voloridge Investment Management's Q1 2017 Portfolio in Review
As of Q1 2017, Voloridge Investment Management held 809 positions worth $4.1B, down 12% from $4.66B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Voloridge Investment Management withdrew a net $793M in Q1 2017, closing 352 positions and reducing 125 holdings. Its most notable exit was NVIDIA, an estimated $140M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 7.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Gilead Sciences worth $125M.
- Voloridge Investment Management's largest Q1 2017 buy was Gilead Sciences: 1,838,868 shares worth $125M.
- Voloridge Investment Management added most to Halliburton in Q1 2017, an estimated $80M increase.
- Voloridge Investment Management's biggest Q1 2017 reduction was Broadcom, cutting an estimated $86M.
- Voloridge Investment Management fully exited NVIDIA in Q1 2017, selling an estimated $140M.
- Voloridge Investment Management's ten largest holdings make up 23% of its $4.1B portfolio in Q1 2017.
- Voloridge Investment Management opened 202 new positions and closed 352 in Q1 2017.
- Voloridge Investment Management's portfolio value fell 12% quarter-over-quarter to $4.1B.
Based on Voloridge Investment Management's 13F filing for Q1 2017, filed 15 May 2017.